Bokus
Abraham Pedroza-Torres, Rosa M. Alvarez-Gomez - Deciphering Cancer Resistance, Häftad

Häftad, Engelska, 2027

Deciphering Cancer Resistance

Mechanisms, Targets, and Emerging Therapies

Av Abraham Pedroza-Torres, Rosa M. Alvarez-Gomez

Del i serien Novel approaches to overcome cancer resistance to conventional therapies

2034 kr

Beställningsvara. Skickas inom 11-20 vardagar. Fri frakt över 249 kr.

Beskrivning
Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies addresses the critical challenge of treatment resistance in oncology. The book provides a comprehensive examination of the cellular, molecular, and genetic mechanisms behind resistance, unveiling insights from cancer biology and genomics that inform novel therapeutic strategies. Sections explore cutting-edge technologies like CAR-T cell therapy, nanotechnology, and artificial intelligence, highlighting their role in discovering new treatment modalities. Readers will find the latest preclinical and clinical data, including newly FDA-approved therapies, demonstrating their potential to improve patient outcomes.

For academics, this resource consolidates the latest research and clinical developments, aiding researchers, clinicians, and students in staying updated on advancements. It will also be a great guide for graduate studies and research, offering critical insights into drug development and targeted therapies for professionals in the pharmaceutical and biotechnology sectors, ultimately driving progress in cancer treatment.

  • Provides an in-depth analysis of cellular, molecular, and genetic mechanisms behind cancer treatment resistance
  • Explores cutting-edge technologies such as CAR-T cell therapy, nanotechnology, and artificial intelligence in addressing resistance
  • Presents the latest preclinical and clinical data, including newly FDA-approved therapies, to enhance patient outcomes
Produktinformation
Utforska kategorier
Mer om författaren

Dr. Pedroza-Torres is a specialist in molecular biology and cancer research, with a focus on identifying molecular markers associated with treatment resistance in ovarian cancer. His research also explores the role of cellular exosomes in modulating the tumor microenvironment and influencing the response to cisplatin therapy. Dr. Alvarez-Gomez is aspecialist in genetics and cancer risk assessment. Currently, she is the chief of the Hereditary Cancer Clinic at National Cancer Institute (INCAN), Mexico. Dr. Alvarez's multidisciplinary clinical and research program emphasizes the relevance of the translational medicine in diagnosis, treatment and assessment of patients with inherited cancer and their families.

Recensioner i media

Select Guide Rating

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.